Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The firm has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The firm conducts its businesses within domestic and overseas markets.
Zai Lab Limited 'in mevcut fiyatı $20.75 'dir, son işlem günde 0% azalmış etti.
Zai Lab Limited için ana iş temaları veya sektörler nelerdir?
Zai Lab Limited Biotechnology endüstrisine ait ve sektör Health Care 'dir
Zai Lab Limited 'in piyasa değerlemesi nedir?
Zai Lab Limited 'in mevcut piyasa değerlemesi $2.3B 'dir
Zai Lab Limited al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 10 analist Zai Lab Limited için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 9 al, 3 tut, 0 sat ve 2 güçlü sat içermektedir